Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company is mainly engaged in selling health supplements and providing original equipment manufacturing (OEM) services. The Company also outsources manufacturing / OEM services.

Employees

Sector

Pharmaceuticals

More about the company

Market Closed - OTC Markets 17:07:15 08/09/2026 +03			5-day change	1st Jan Change
0.1819 ^USD	-4.26%		0.00%	+203.17%

08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-19	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI

Market Cap	9.79M 8.54M 8.06M 7.32M 13.71M 939M 13.77M 96.54M 37.25M 477M 36.77M 35.95M 1.54B	P/E 2024	-7x	P/E 2025	2.54x
Enterprise Value	11.35M 9.9M 9.35M 8.49M 15.9M 1.09B 15.97M 112M 43.2M 554M 42.64M 41.69M 1.78B	EV / Sales 2024	36.6x	EV / Sales 2025	2.03x
Free-Float	36.08%	Yield 2024 *	-	Yield 2025	-

08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-19	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-25	Bio Essence Corporation has entered into a Asset Purchase Agreement to acquire MediFlow AI from Zhituo Software Co., Limited for $3.1 million.	CI
03-27	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
11-12	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
28/03/25	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/03/25	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
14/11/24	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
20/08/24	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

11-12	Bio Essence : Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q)	PU
07/10/24	Bio Essence : Amendment to Quarterly Report Form 10 Q/A	PU
07/10/24	Bio Essence : Non Reliance of Financial Report Form 8 K	PU
30/03/23	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
16/05/22	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ

Bio Essence Corporation Stock

Stocks

BIOE

US09090C1053

Pharmaceuticals

Valuation: Bio Essence Corporation

Chart: Bio Essence Corporation

Latest news: Bio Essence Corporation

Press Releases: Bio Essence Corporation

Quotes and Performance

Price Extremes

Managers and Directors: Bio Essence Corporation

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

1 day	-4.26%
Current month	-4.26%
1 month	-27.24%
6 months	+9.71%
Current year	+203.17%

1 month	0.18	0.19
Current year	0.05	0.52
1 year	0.05	0.52
3 years	0.05	10.81
5 years	0.05	10.81
10 years	0.05	10.81

Manager	Title	Age	Since
Yin Yan CEO	Chief Executive Officer	50	-
Bill Sluss DFI	Director of Finance/CFO	71	07/09/2023
Tuan Tran COO	Chief Operating Officer	52	01/01/2018

Director	Title	Age	Since
Yin Yan CHM	Chairman	50	-
Siyavash Fooladian BRD	Director/Board Member	54	-
Bill Sluss BRD	Director/Board Member	71	18/06/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/28/24 A	Yin Yan	Sell	Chief Executive Officer	323,845	0.8520%
7/11/24 A	Yin Yan	Sell	Chief Executive Officer	92,190	0.2425%
7/2/24 A	Yin Yan	Sell	Chief Executive Officer	223,965	0.5892%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIO ESSENCE CORPORATION	-4.26%	0.00%	+97.72%	-64.33%	9.79M
ELI LILLY AND COMPANY	+0.04%	+3.34%	+53.32%	+100.52%	1,028B
JOHNSON & JOHNSON	-0.09%	+1.66%	+53.24%	+66.45%	651B
ABBVIE INC.	-0.02%	+2.66%	+18.65%	+71.97%	466B
ROCHE HOLDING AG	-1.22%	+3.66%	+34.59%	+38.81%	346B
NOVARTIS AG	-0.79%	+2.73%	+17.73%	+25.11%	266B
ASTRAZENECA PLC	+0.58%	+6.76%	+10.58%	+17.75%	259B
AMGEN INC.	+1.55%	+2.20%	+35.12%	+45.91%	208B
NOVO NORDISK A/S	+0.79%	+1.84%	-27.55%	-56.48%	191B
GILEAD SCIENCES, INC.	-0.52%	+4.45%	+31.57%	+98.11%	186B
Average	-0.39%	+2.93%	+32.50%	+34.38%	360.17B
Weighted average by Cap.	-0.04%	+3.09%	+34.84%	+61.60%

	2024	2025
Net sales	324K 282K 267K 242K 454K 31.08M 456K 3.19M 1.23M 15.8M 1.22M 1.19M 50.85M	1.9M 1.65M 1.56M 1.42M 2.66M 182M 2.67M 18.72M 7.22M 92.57M 7.13M 6.97M 298M
Net income	-1.31M -1.14M -1.08M -979K -1.83M -126M -1.84M -12.91M -4.98M -63.85M -4.92M -4.81M -205M	896K 781K 738K 670K 1.26M 85.99M 1.26M 8.84M 3.41M 43.72M 3.37M 3.29M 141M
Net Debt	2.7M 2.36M 2.23M 2.02M 3.79M 259M 3.8M 26.66M 10.29M 132M 10.16M 9.93M 424M	1.56M 1.36M 1.29M 1.17M 2.19M 150M 2.2M 15.42M 5.95M 76.25M 5.87M 5.74M 245M